Bind-X

Planegg, Germany

Bind-X develops biotechnology applications to improve the sustainability of industries by optimizing biotechnological processes.

$11.0M raised

Aug 2023

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Bind-X raised?

Bind-X has raised $11.0M in total funding. The most recent round was Series B. The last funding was announced in August 2023.

Who are Bind-X's investors?

Bind-X's investors include HTGF (High-Tech Gruenderfonds), HG Ventures, Saxovent, Greeneering Invest, Vantage Value.

Where is Bind-X headquartered?

Bind-X is headquartered in Planegg, Germany.

What does Bind-X do?

Bind-X develops biotechnology applications to improve the sustainability of industries by optimizing biotechnological processes.

What stage is Bind-X at?

Bind-X is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 1, 2023.

MLA

"Bind-X — Funding & Investors." VCBacked, August 1, 2023, https://www.vcbacked.co/company/bind-x. Accessed July 2, 2026.

APA

VCBacked. (2023). Bind-X — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/bind-x

Wikipedia (cite web)

{{cite web |title=Bind-X — Funding & Investors |url=https://www.vcbacked.co/company/bind-x |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 1, 2023.